Immune cell helps predict skin cancer patients’ responses to immunotherapies Vd1-gd T cells were effective in predicting positive responses to ICI therapy
Risk model predicts response and survival of cancer patients treated with ICIs Metastatic cancer is estimated to be responsible for 90% of cancer deaths